|Bid||0.2550 x 0|
|Ask||0.2800 x 0|
|Day's Range||0.2500 - 0.2800|
|52 Week Range||0.0300 - 0.4300|
|Beta (5Y Monthly)||-0.09|
|PE Ratio (TTM)||18.67|
|Earnings Date||May 20, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
GBLT Corp. (TSXV: GBLT) (OTCQB: GBLTF) (FSE: 4G9) ("GBLT" or the "Company") is pleased to announce that it has received an order for its proprietary Dr. Senst branded thermometers from one of the world's largest retailers, amounting to €4.4m. The order is deliverable in the first half of 2022 and represents continued market penetration of the Company's growing Dr. Senst branded healthcare solutions in Germany, Italy, France and Poland.
GBLT Corp. (TSXV: GBLT) (OTCQB: GBLTF) (FSE: 4G9) ("GBLT" or the "Company") is pleased to announce that it has received an additional order of USD $2.5m for private label batteries, deliverable in Q3 & Q4 2021, from one of the five largest drug store chains (the "Client") in the world. This is the second order from the Client in 2021 and marks a significant expansion from the initial order of USD $3.3m and significantly exceeds the expected order size.
GBLT Corp. (TSXV: GBLT) (OTCQB: GBLTF) (FSE: 4G9) ("GBLT" or the "Company") is pleased to announce that it has expanded its licensee agreement with AgfaPhoto Holding GmbH ("AgfaPhoto") to allow GBLT to provide AgfaPhoto's entire suite of mobile energy and storage solutions products globally. As a result of overwhelming demand for AgfaPhoto products delivered to GBLT customers in Europe, AgfaPhoto has extended the term of the license to December 31, 2026 that was initially scheduled to terminate